Terms: = Gastric cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
8692 results:
1. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
2. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
3. Surgeon age in relation to patients' long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study.
Leijonmarck W; Mattsson F; Asplund J; Markar S; Lagergren J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38669194
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
[TBL] [Abstract] [Full Text] [Related]
5. Extent of Virulence and Antibiotic Resistance Genes in Helicobacter pylori and Campylobacteria.
Rao RSP; Ghate SD; Pinto L; Suravajhala P; Patil P; Shetty P; Ahsan N
Curr Microbiol; 2024 Apr; 81(6):154. PubMed ID: 38652129
[TBL] [Abstract] [Full Text] [Related]
6. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
7. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
8. Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer.
Choi Y; Lee J; Shin K; Lee JW; Kim JW; Lee S; Choi YJ; Park KH; Kim JH
BMC Cancer; 2024 Apr; 24(1):502. PubMed ID: 38643078
[TBL] [Abstract] [Full Text] [Related]
9. Nationwide Association of Surgical Performance of Minimally Invasive Esophagectomy With Patient Outcomes.
Ketel MHM; Klarenbeek BR; Abma I; Belgers EHJ; Coene PLO; Dekker JWT; van Duijvendijk P; Emous M; Gisbertz SS; Haveman JW; Heisterkamp J; Nieuwenhuijzen GAP; Ruurda JP; van Sandick JW; van der Sluis PC; van Det MJ; van Esser S; Law S; de Steur WO; Sosef MN; Wijnhoven B; Hannink G; Rosman C; van Workum F;
JAMA Netw Open; 2024 Apr; 7(4):e246556. PubMed ID: 38639938
[TBL] [Abstract] [Full Text] [Related]
10. Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study.
Li J; Fong DYT; Lok KYW; Wong JYH; Man Ho M; Choi EPH; Pandian V; Davidson PM; Duan W; Tarrant M; Lee JJ; Lin CC; Akingbade O; Alabdulwahhab KM; Ahmad MS; Alboraie M; Alzahrani MA; Bilimale AS; Boonpatcharanon S; Byiringiro S; Hasan MKC; Schettini LC; Corzo W; De Leon JM; De Leon AS; Deek H; Efficace F; El Nayal MA; El-Raey F; Ensaldo-Carrasco E; Escotorin P; Fadodun OA; Fawole IO; Goh YS; Irawan D; Khan NE; Koirala B; Krishna A; Kwok C; Le TT; Leal DG; Lezana-Fernández MÁ; Manirambona E; Mantoani LC; Meneses-González F; Mohamed IE; Mukeshimana M; Nguyen CTM; Nguyen HTT; Nguyen KT; Nguyen ST; Nurumal MS; Nzabonimana A; Omer NAMA; Ogungbe O; Poon ACY; Reséndiz-Rodriguez A; Puang-Ngern B; Sagun CG; Shaik RA; Shankar NG; Sommer K; Toro E; Tran HTH; Urgel EL; Uwiringiyimana E; Vanichbuncha T; Youssef N
J Glob Health; 2024 Apr; 14():04068. PubMed ID: 38606605
[TBL] [Abstract] [Full Text] [Related]
11. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
[TBL] [Abstract] [Full Text] [Related]
12. gastric adenocarcinoma location and postoperative complication rates in Asian patients: A 2014-2019 NSQIP analysis.
Lew R; Cheng S; Chun I; Ishikawa K; Ahn HJ; Wai C
Am J Surg; 2024 Jan; 227():208-212. PubMed ID: 38587050
[TBL] [Abstract] [Full Text] [Related]
13. Endoscopic diagnosis of gastric and oesophageal cancer in Lusaka, Zambia: a retrospective analysis.
Kayamba V; Mubbunu M; Kelly P
BMC Gastroenterol; 2024 Apr; 24(1):122. PubMed ID: 38561688
[TBL] [Abstract] [Full Text] [Related]
14. Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.
Gal O; Lewin R; Perl G; Ulitzky O; Brenner B; Kundel Y
J Cancer Res Ther; 2024 Jan; 20(1):281-284. PubMed ID: 38554334
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of HLA-DR and HLA-DQ expression in gastric cancer tissues.
Jafari N; Khajenabi F; Masumi N; Abediankenari S; Ranjbaran H
J Cancer Res Ther; 2024 Jan; 20(1):204-210. PubMed ID: 38554322
[TBL] [Abstract] [Full Text] [Related]
16. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis.
Eskandarion MR; Eskandarieh S; Tutunchi S; Shakoori Farahani A; Shirkoohi R
Clin Exp Med; 2024 Mar; 24(1):59. PubMed ID: 38554188
[TBL] [Abstract] [Full Text] [Related]
17. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract] [Full Text] [Related]
18. National clinical and financial outcomes associated with acute kidney injury following esophagectomy for cancer.
Ng AP; Chervu N; Branche C; Bakhtiyar SS; Marzban M; Toste PA; Benharash P
PLoS One; 2024; 19(3):e0300876. PubMed ID: 38547215
[TBL] [Abstract] [Full Text] [Related]
19. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
[No Abstract] [Full Text] [Related]
20. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
[TBL] [Abstract] [Full Text] [Related]
[Next]
